Antibodies
3 January 2017
Glenmark Pharmaceuticals Receives FDA Clearance of IND for GBR 1302-BEAT™ Phase I Trial1 January 2017
BeiGene Announces First Patient Dosing in China Phase I Trial with Investigational Anti-PD-1 Monoclonal Antibody BGB-A31727 December 2016
Seattle Genetics Announces Clinical Hold on Several Phase 1 Trials of Vadastuximab Talirine (SGN-CD33A)23 December 2016
New Research Suggests Role for Aravive Biologics’ Anti-AXL Candidate for Increasing Tumor Sensitivity to Radiation and Check-point Inhibitors23 December 2016
Acceleron Announces First Patient Treated in Phase 2 Trial of ACE-083 in Facioscapulohumeral Muscular Dystrophy22 December 2016
Chugai’s Bispecific Antibody “Emicizumab” for Hemophilia A Meets Primary Endpoint in Phase lll Study22 December 2016
Positive Phase III Results of Genentech’s Investigational Medicine Ocrevus™ (Ocrelizumab) Published in New England Journal of Medicine22 December 2016
Merrimack Stops the Phase 2 HERMIONE Trial of MM-302 in HER2-Positive Metastatic Breast Cancer Patients19 December 2016
More than ever antibody-drug conjugates generated by new technologies are undergoing clinical proof-of-concept testing19 December 2016
Samsung Bioepis’ Type II Variation Application for Indication Extension of Benepali® Receives Positive CHMP Opinion17 December 2016
Novartis receives positive CHMP recommendation for Ilaris® to treat rare diseases in adults and children called Periodic Fever Syndromes17 December 2016
argenx launches Phase I/II study of ARGX-110 in combination with azacitidine in newly diagnosed AML patients17 December 2016
CHMP recommends EU conditional approval of Roche’s Alecensa (alectinib) for people with previously treated ALK-positive NSCLCNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports